 |
|
|
| |
Psychiatric Adverse Events From the DTG ART-Naive Phase III/IIIb Clinical Trials
|
| |
| |
Reported by Jules Levin
HIV Glasgow Oct 23-26 2016
Romina Quercia,1Jeremy Roberts,2Andrew Murungi,1Lloyd Curtis,3Nassrin Payvandi,1Justin Koteff,4Michael Aboud1
1ViiV Healthcare, Brentford, UK; 2GlaxoSmithKline, Mississauga, Ontario, Canada; 3GlaxoSmithKline, Stockley Park, UK; 4ViiV Healthcare, Research Triangle Park, NC, USA
|
| |
|
|
|
|
|
